Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis

Summary

This randomized clinical trial aims to determine if cells from a patient's own adipose tissue is safe and capable of helping regenerate the femoral head in patients with osteonecrosis. The standard of care is known as hip decompression which simply removes dead tissue from the femoral head and creates a new cavity to be filled in by healthy bone. This trial will use hip decompression in one hip and hip decompression supplemented with adipose derived regenerative cells in patients with osteonecrosis in both of their hips.

Timeline

Start

2017-11-15

Primary completion

2021-06-28

Completion

2021-06-28

Drugs

Indications